Form 4: Integer Holdings Director Michael J. Coyle Granted Restricted Stock Units

Sentiment:

Insider Transaction Report


Integer Holdings Corp Director Michael J. Coyle was granted 1,355 restricted stock units, vesting in installments through May 2026.

Summary

  • Michael J. Coyle, a Director of Integer Holdings Corp (ITGR), was granted 1,355 restricted stock units (RSUs).
  • The grant date for these RSUs was July 10, 2025.
  • These RSUs convert into common stock on a one-for-one basis.
  • The vesting schedule for the RSUs is in approximately equal installments on August 21, 2025, November 21, 2025, February 21, 2026, and May 19, 2026.
  • Following this transaction, Michael J. Coyle beneficially owns 1,355 shares directly.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally a positive sign as it aligns interests with shareholders and is a standard compensation practice, indicating stability in governance. No negative implications are present.

Positives

  • The grant of restricted stock units to a director aligns the director's interests with long-term shareholder value through equity ownership.
  • The vesting schedule encourages continued commitment and performance from the director over a multi-year period.

Future Outlook

The vesting schedule for the granted restricted stock units extends through May 2026, indicating a future alignment of the director's interests with the company's long-term performance.

Industry Context

Equity grants to directors are a common practice across various industries, including the medical device and manufacturing sector where Integer Holdings Corp operates. This practice is designed to align the interests of board members with those of shareholders by providing a direct stake in the company's long-term performance.

Comparison to Industry Standards

  • The grant of restricted stock units (RSUs) as a form of director compensation is a standard practice in publicly traded companies, comparable to compensation structures at peers in the medical device industry such as Medtronic, Stryker, or Boston Scientific, which often include equity components to incentivize long-term value creation.
  • The vesting schedule, extending over multiple quarters, is typical for RSU grants to ensure retention and sustained commitment from board members, aligning with corporate governance best practices observed across the S&P 500.

Stakeholder Impact

  • Shareholders: The grant of equity to a director aligns their interests with shareholders, potentially fostering decisions that enhance long-term shareholder value.
  • Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

  • Vesting of restricted stock units in approximately equal installments on August 21, 2025.
  • Vesting of restricted stock units in approximately equal installments on November 21, 2025.
  • Vesting of restricted stock units in approximately equal installments on February 21, 2026.
  • Vesting of restricted stock units in approximately equal installments on May 19, 2026.

Key Dates

DateDescription
07/10/2025Date of earliest transaction: Grant of 1,355 restricted stock units to Michael J. Coyle.
08/21/2025First approximate vesting installment date for restricted stock units.
11/21/2025Second approximate vesting installment date for restricted stock units.
02/21/2026Third approximate vesting installment date for restricted stock units.
05/19/2026Fourth approximate vesting installment date for restricted stock units.
07/14/2025Date the Form 4 was signed by attorney-in-fact for Michael J. Coyle.

Recommendation

hold

Keywords

Integer Holdings Corp, ITGR, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Michael J. Coyle

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.